Antimicrobial effect of auranofin against Acanthamoeba spp

Alvie Loufouma Mbouaka1, David Leitsch1, Martina Koehsler1

  • 1Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria.

Insights

Auranofin demonstrates potent antimicrobial activity against Acanthamoeba species. This gold-based compound shows promise for preventing and treating serious Acanthamoeba infections like keratitis and encephalitis.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Acanthamoeba are opportunistic pathogens causing severe infections such as Acanthamoeba keratitis and granulomatous amoebic encephalitis.
  • Current treatment options for Acanthamoeba infections are limited and unsatisfactory.
  • Novel therapeutic strategies are urgently needed to combat these challenging parasitic infections.

Purpose of the Study:

  • To evaluate the in vitro efficacy of the gold-based compound auranofin against Acanthamoeba species.

Main Methods:

  • In vitro assessment of auranofin's antimicrobial activity.
  • Determination of the inhibitory concentration 50 (IC50) values for auranofin against Acanthamoeba spp.

Main Results:

  • Auranofin exhibited potent antimicrobial activity against Acanthamoeba species.
  • The IC50 values ranged from 2.9 to 3.48 µM, indicating significant efficacy.

Conclusions:

  • Auranofin possesses significant in vitro activity against Acanthamoeba.
  • Auranofin may serve as a potential therapeutic agent for the prevention and control of Acanthamoeba infections.